Pretreatment of caffeine leads to partial neuroprotection in MPTP model of Parkinson's disease
Main Authors: | Puneet Bagga, Anant B Patel |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Neural Regeneration Research |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2016;volume=11;issue=11;spage=1750;epage=1751;aulast=Bagga |
Similar Items
-
Amiloride is neuroprotective in an MPTP model of Parkinson's disease
by: Robert L. Arias, et al.
Published: (2008-09-01) -
The Neuroprotective Effects of Cinnamic Aldehyde in an MPTP Mouse Model of Parkinson’s Disease
by: Woom-Yee Bae, et al.
Published: (2018-02-01) -
Intranasal mucoadhesivemicroemulsion for neuroprotective effect of curcuminin mptp induced Parkinson model
by: Snigdha Das Mandal, et al.
Published: (2017-06-01) -
Catalpol Exerts a Neuroprotective Effect in the MPTP Mouse Model of Parkinson’s Disease
by: Li-Yuan Wang, et al.
Published: (2019-11-01) -
TFP5/TP5 peptide provides neuroprotection in the MPTP model of Parkinson′s disease
by: B K Binukumar, et al.
Published: (2016-01-01)